Genky DrugStores Gelecekteki Büyüme

Future kriter kontrolleri 3/6

Genky DrugStores kazanç ve gelirin sırasıyla yıllık 8.6% ve 8.3% oranında artacağı tahmin edilmektedir. EPS'nin yıllık 8.6% oranında büyümesi beklenmektedir. Özkaynak kârlılığının 3 yıl içinde 13.3% olacağı tahmin edilmektedir.

Anahtar bilgiler

8.6%

Kazanç büyüme oranı

8.6%

EPS büyüme oranı

Consumer Retailing kazanç büyümesi	12.9%
Gelir büyüme oranı	8.3%
Gelecekteki özkaynak getirisi	13.3%
Analist kapsamı	Low
Son güncelleme	28 Oct 2024

Gelecekteki son büyüme güncellemeleri

Genky DrugStores Co., Ltd. (TSE:9267) Just Reported And Analysts Have Been Lifting Their Price Targets

Oct 30

Earnings Update: Here's Why Analysts Just Lifted Their Genky DrugStores Co., Ltd. (TSE:9267) Price Target To JP¥7,600

Apr 27

Recent updates

Genky DrugStores Co., Ltd. (TSE:9267) Just Reported And Analysts Have Been Lifting Their Price Targets

Oct 30

What Genky DrugStores Co., Ltd.'s (TSE:9267) 28% Share Price Gain Is Not Telling You

Aug 07

Earnings Update: Here's Why Analysts Just Lifted Their Genky DrugStores Co., Ltd. (TSE:9267) Price Target To JP¥7,600

Apr 27

Return Trends At Genky DrugStores (TSE:9267) Aren't Appealing

Mar 07

Kazanç ve Gelir Büyüme Tahminleri

TSE:9267 - Analistlerin gelecek tahminleri ve geçmiş finansal verileri (JPY Millions )
Tarih	Gelir	Kazançlar	Serbest Nakit Akışı	Faaliyetlerden Nakit	Avg. Analist Sayısı
6/30/2027	240,850	8,610	-52	N/A	2
6/30/2026	221,700	7,851	-91	N/A	2
6/30/2025	203,900	7,210	-818	N/A	2
9/20/2024	188,039	6,464	N/A	N/A	N/A
6/20/2024	184,860	6,324	2,815	13,256	N/A
3/20/2024	181,441	5,907	N/A	N/A	N/A
12/20/2023	177,152	5,580	-1,512	10,740	N/A
9/20/2023	173,317	5,106	N/A	N/A	N/A
6/20/2023	169,059	4,764	-1,155	8,773	N/A
3/20/2023	165,078	4,668	N/A	N/A	N/A
12/20/2022	162,272	4,559	-1,123	9,177	N/A
9/20/2022	158,134	4,290	N/A	N/A	N/A
6/20/2022	154,639	4,420	-4,431	6,076	N/A
3/20/2022	152,692	4,484	N/A	N/A	N/A
12/20/2021	149,500	4,527	-240	8,809	N/A
9/20/2021	146,419	4,775	N/A	N/A	N/A
6/20/2021	142,376	4,831	3,121	12,075	N/A
3/20/2021	140,851	4,449	N/A	N/A	N/A
12/20/2020	136,390	4,455	2,338	11,396	N/A
9/20/2020	130,173	3,565	N/A	N/A	N/A
6/20/2020	123,603	2,755	-3,594	7,411	N/A
3/20/2020	113,707	2,268	N/A	N/A	N/A
12/20/2019	108,305	1,958	-7,861	2,946	N/A
9/20/2019	105,832	2,334	N/A	N/A	N/A
6/20/2019	103,897	2,697	-6,422	4,300	N/A
3/20/2019	101,948	3,275	N/A	N/A	N/A
12/20/2018	100,167	3,179	-3,257	4,694	N/A
9/20/2018	97,753	3,178	N/A	N/A	N/A
6/20/2018	94,869	3,118	N/A	5,365	N/A
3/20/2018	92,031	2,972	N/A	N/A	N/A
12/20/2017	89,301	2,880	N/A	6,866	N/A
9/20/2017	86,379	2,867	N/A	N/A	N/A
6/20/2017	83,399	2,845	N/A	5,238	N/A
3/20/2017	80,879	2,603	N/A	N/A	N/A
12/20/2016	78,640	2,462	N/A	2,805	N/A
9/20/2016	76,170	2,223	N/A	N/A	N/A
6/20/2016	73,495	1,901	N/A	2,695	N/A
3/20/2016	70,426	1,643	N/A	N/A	N/A
12/20/2015	67,761	1,740	N/A	3,498	N/A
9/20/2015	65,413	1,743	N/A	N/A	N/A
6/20/2015	63,143	1,761	N/A	4,758	N/A
3/20/2015	61,524	1,819	N/A	N/A	N/A
12/20/2014	60,811	1,635	N/A	3,767	N/A
9/20/2014	59,853	1,452	N/A	N/A	N/A
6/20/2014	57,949	1,171	N/A	3,662	N/A
3/20/2014	56,365	944	N/A	N/A	N/A
12/20/2013	54,710	768	N/A	3,446	N/A

Analist Gelecek Büyüme Tahminleri

Kazançlar ve Tasarruf Oranları: 9267 'nin tahmini kazanç büyümesi (yıllık 8.6% ) tasarruf oranının ( 0.3% ) üzerindedir.

Kazançlar ve Piyasa: 9267 şirketinin kazançlarının (yıllık 8.6% ) JP pazarından (yıllık 7.9% ) daha hızlı büyümesi öngörülüyor.

Yüksek Büyüme Kazançları: 9267 şirketinin kazançlarının artması bekleniyor, ancak önemli ölçüde.

Gelir ve Pazar: 9267 şirketinin gelirinin (yıllık 8.3% ) JP pazarından (yıllık 4.1% ) daha hızlı büyümesi öngörülüyor.

Yüksek Büyüme Geliri: 9267 şirketinin gelirinin (yıllık 8.3% ) yıllık 20% oranından daha yavaş büyümesi öngörülüyor.

Hisse Başına Kazanç Büyüme Tahminleri

Gelecekteki Özkaynak Getirisi

Gelecekteki ROE: 9267 'nin Özsermaye Getirisi'nin 3 yıl içinde düşük olması tahmin ediliyor ( 13.3 %).

Genky DrugStores Gelecekteki Büyüme

Future kriter kontrolleri 3/6

Anahtar bilgiler

Gelecekteki son büyüme güncellemeleri

Genky DrugStores Co., Ltd. (TSE:9267) Just Reported And Analysts Have Been Lifting Their Price Targets

Price target increased by 11% to JP¥4,300

Earnings Update: Here's Why Analysts Just Lifted Their Genky DrugStores Co., Ltd. (TSE:9267) Price Target To JP¥7,600

Consensus EPS estimates increase by 13%

Genky DrugStores Co., Ltd. Provides Consolidated Earnings Guidance for the Fiscal Year Ending June 20, 2024

Price target increased by 9.3% to JP¥4,700

Recent updates

Genky DrugStores Co., Ltd. to Report Q2, 2025 Results on Jan 27, 2025

Genky DrugStores Co., Ltd. (TSE:9267) Just Reported And Analysts Have Been Lifting Their Price Targets

First quarter 2025 earnings released: EPS: JP¥52.13 (vs JP¥47.54 in 1Q 2024)

Final dividend of JP¥6.50 announced

Price target increased by 11% to JP¥4,300

Genky DrugStores Co., Ltd. to Report Q1, 2025 Results on Oct 28, 2024

What Genky DrugStores Co., Ltd.'s (TSE:9267) 28% Share Price Gain Is Not Telling You

Full year 2024 earnings: EPS exceeds analyst expectations

New minor risk - Share price stability

Investor sentiment improves as stock rises 21%

Genky DrugStores Co., Ltd., Annual General Meeting, Sep 12, 2024

Upcoming dividend of JP¥13.00 per share

Genky DrugStores Co., Ltd. to Report Fiscal Year 2024 Results on Jul 29, 2024

Earnings Update: Here's Why Analysts Just Lifted Their Genky DrugStores Co., Ltd. (TSE:9267) Price Target To JP¥7,600

Third quarter 2024 earnings released: EPS: JP¥90.14 (vs JP¥68.63 in 3Q 2023)

Consensus EPS estimates increase by 13%

Return Trends At Genky DrugStores (TSE:9267) Aren't Appealing

Genky DrugStores Co., Ltd. to Report Q3, 2024 Results on Apr 25, 2024

First half dividend of JP¥12.50 announced

Second quarter 2024 earnings released: EPS: JP¥108 (vs JP¥77.00 in 2Q 2023)

Genky DrugStores Co., Ltd. Provides Consolidated Earnings Guidance for the Fiscal Year Ending June 20, 2024

New minor risk - Share price stability

Upcoming dividend of JP¥12.50 per share at 0.5% yield

Genky DrugStores Co., Ltd. to Report Q2, 2024 Results on Jan 29, 2024

First quarter 2024 earnings released: EPS: JP¥95.08 (vs JP¥72.58 in 1Q 2023)

Genky Drugstores Co., Ltd. Provides Dividend Guidance for Second Quarter and Full Year of Year Ending June 20, 2024

Genky DrugStores Co., Ltd. to Report Q1, 2024 Results on Oct 30, 2023

Full year 2023 earnings: EPS exceeds analyst expectations

Genky DrugStores Co., Ltd., Annual General Meeting, Sep 07, 2023

New minor risk - Share price stability

Investor sentiment improves as stock rises 17%

Upcoming dividend of JP¥12.50 per share at 0.6% yield

Genky DrugStores Co., Ltd. to Report Fiscal Year 2023 Results on Jul 24, 2023

Third quarter 2023 earnings released: EPS: JP¥68.63 (vs JP¥61.46 in 3Q 2022)

Price target increased by 9.3% to JP¥4,700

Genky DrugStores Co., Ltd. Provides Consolidated Earnings Guidance for the Fiscal Year Ending June 20, 2023

Second quarter 2023 earnings released: EPS: JP¥77.00 (vs JP¥59.30 in 2Q 2022)

Genky DrugStores Co., Ltd. to Report Q2, 2023 Results on Jan 31, 2023

Upcoming dividend of JP¥12.50 per share

Less than half of directors are independent

First quarter 2023 earnings released: EPS: JP¥72.58 (vs JP¥81.18 in 1Q 2022)

Genky DrugStores Co., Ltd. Provides Consolidated Earnings Guidance for the First Half of Fiscal Year Ending June 20, 2023 and Full Year Ending June 20, 2023

Genky DrugStores Co., Ltd. to Report Q1, 2023 Results on Oct 24, 2022

Consensus EPS estimates fall by 12%

Full year 2022 earnings: EPS exceeds analyst expectations while revenues lag behind

Genky Drugstores Co., Ltd. Provides Consolidated Earnings Guidance for the First Half and Full Year of Fiscal Year Ending June 20, 2023

Genky DrugStores Co., Ltd. to Report Fiscal Year 2022 Results on Jul 26, 2022

Upcoming dividend of JP¥12.50 per share

Third quarter 2022 earnings: EPS exceeds analyst expectations while revenues lag behind

Price target decreased to JP¥5,700

Less than half of directors are independent

Genky DrugStores Co., Ltd. to Report Q3, 2022 Results on Apr 26, 2022

Second quarter 2022 earnings: EPS and revenues exceed analyst expectations

Genky Drugstores Co., Ltd. Provides Earnings Guidance for the Fiscal Year Ending June 30, 2022

Investor sentiment deteriorated over the past week

Investor sentiment improved over the past week

Upcoming dividend of JP¥12.50 per share

First quarter 2022 earnings released: EPS JP¥81.18 (vs JP¥84.86 in 1Q 2021)

Full year 2021 earnings released: EPS JP¥318 (vs JP¥182 in FY 2020)

Upcoming dividend of JP¥12.50 per share

Third quarter 2021 earnings released: EPS JP¥64.31 (vs JP¥64.70 in 3Q 2020)

Genky DrugStores Co., Ltd. to Report Q3, 2021 Results on Apr 20, 2021

New 90-day low: JP¥3,720

New 90-day low: JP¥3,795

Second quarter 2021 earnings released: EPS JP¥75.64

Upcoming Dividend of JP¥12.50 Per Share

Genky DrugStores Co., Ltd. to Report Q2, 2021 Results on Jan 20, 2021

Genky DrugStores Co., Ltd. to Report Q1, 2021 Results on Oct 20, 2020

Kazanç ve Gelir Büyüme Tahminleri